Cochlear Ltd Adr Stock Current Valuation
| CHEOY Stock | USD 99.89 0.45 0.45% |
Valuation analysis of CochLear ADR helps investors to measure CochLear's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Fairly Valued
Today
Please note that CochLear's price fluctuation is very steady at this time. Calculation of the real value of CochLear ADR is based on 3 months time horizon. Increasing CochLear's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since CochLear is currently traded on the exchange, buyers and sellers on that exchange determine the market value of CochLear Pink Sheet. However, CochLear's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 99.89 | Real 99.07 | Hype 99.89 | Naive 98.45 |
The intrinsic value of CochLear's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence CochLear's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of CochLear Ltd ADR helps investors to forecast how CochLear pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of CochLear more accurately as focusing exclusively on CochLear's fundamentals will not take into account other important factors: CochLear Ltd ADR Company Current Valuation Analysis
CochLear's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current CochLear Current Valuation | 9.05 B |
Most of CochLear's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CochLear Ltd ADR is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, CochLear Ltd ADR has a Current Valuation of 9.05 B. This is 37.01% lower than that of the Healthcare sector and 27.17% lower than that of the Medical Devices industry. The current valuation for all United States stocks is 45.58% higher than that of the company.
CochLear Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CochLear's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of CochLear could also be used in its relative valuation, which is a method of valuing CochLear by comparing valuation metrics of similar companies.CochLear is currently under evaluation in current valuation category among its peers.
CochLear Fundamentals
| Return On Equity | 0.17 | |||
| Return On Asset | 0.0973 | |||
| Profit Margin | 0.18 % | |||
| Operating Margin | 0.23 % | |||
| Current Valuation | 9.05 B | |||
| Shares Outstanding | 131.56 M | |||
| Price To Earning | 49.26 X | |||
| Price To Book | 8.15 X | |||
| Price To Sales | 5.55 X | |||
| Revenue | 1.65 B | |||
| Gross Profit | 1.24 B | |||
| EBITDA | 475.4 M | |||
| Net Income | 289.1 M | |||
| Cash And Equivalents | 629.3 M | |||
| Cash Per Share | 4.78 X | |||
| Total Debt | 253.9 M | |||
| Debt To Equity | 0.15 % | |||
| Current Ratio | 2.52 X | |||
| Book Value Per Share | 12.81 X | |||
| Cash Flow From Operations | 376.5 M | |||
| Earnings Per Share | 1.53 X | |||
| Number Of Employees | 4.5 K | |||
| Beta | 0.43 | |||
| Market Capitalization | 9.71 B | |||
| Total Asset | 2.47 B | |||
| Retained Earnings | 304 M | |||
| Working Capital | 292 M | |||
| Current Asset | 543 M | |||
| Current Liabilities | 251 M | |||
| Z Score | 22.8 | |||
| Annual Yield | 0.01 % | |||
| Five Year Return | 1.39 % | |||
| Net Asset | 2.47 B | |||
| Last Dividend Paid | 3.0 |
About CochLear Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CochLear Ltd ADR's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CochLear using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CochLear Ltd ADR based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for CochLear Pink Sheet Analysis
When running CochLear's price analysis, check to measure CochLear's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CochLear is operating at the current time. Most of CochLear's value examination focuses on studying past and present price action to predict the probability of CochLear's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CochLear's price. Additionally, you may evaluate how the addition of CochLear to your portfolios can decrease your overall portfolio volatility.